For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

N-gene Research Laboratories, Inc.

USPTO Granted Patents = 14

EPO Patents = 3

Forward Citations = 49

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Balázs Sümegi (4 out of 7 patents)

Péter Literáti Nagy (3 out of 5 patents)

Zoltán Szilvássy (3 out of 3 patents)

4. Balázs Sümegi (3 out of 3 patents)

5. György Rabloczky (2 out of 2 patents)

6. András Rabloczky, Legal Representative (2 out of 2 patents)

7. Kálmán Tory (2 out of 3 patents)

8. József Mandl (2 out of 2 patents)

9. Mark Anthony Febbraio (1 out of 1 patent)

10. Frances Brenda Lefcort (1 out of 1 patent)

11. László Vígh (1 out of 4 patents)

12. Gábor Balogh (1 out of 14 patents)

13. Sándor Bernáth (1 out of 3 patents)

14. Peter Nagy (1 out of 7 patents)

15. Zoltan Szilvassy (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 11357768 - Methods for treating NASH and for preventing NASH-induced HCC (2022-06-14),

2. 10702514 - Use of BGP15 to treat familial dysautonomia (2020-07-07),

3. 8048873 - Synergistic pharmaceutical combination for the prevention or treatment of diabetes (2011-11-01),

4. 7767694 - Pharmaceutical composition having prokinetic effect (2010-08-03),

5. 7763601 - Prevention and treatment of obesity (2010-07-27),

6. 7635674 - Synergistic pharmaceutical combination for the prevention or treatment of diabetes (2009-12-22),

7. 7151175 - Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same (2006-12-19),

8. 6884424 - Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight (2005-04-26),

9. 6838469 - Pharmaceutical composition that exhibits reduced side-effects comprising O-(3-piperidino-2-hydroxy-1-propyl)nicotinic acid amidoxime and a pyrimidine derivative with known antitumor activity (2005-01-04),

10. 6720337 - Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroxlmic acid derivative (2004-04-13),

11. 6656955 - Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative (2003-12-02),

12. 6500823 - Unsaturated hydroximic acid derivatives as per abstract inhibitors (2002-12-31),

13. 6451851 - Pharmaceutical composition with antiviral activity containing an hydroxymic acid derivative and an antiviral agent (2002-09-17),

14. 6440998 - Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing an antitumor agent and an hydroximic acid derivative (2002-08-27),

N-GENE RESEARCH LABORATORIES, INC. is a leading biotechnology company specializing in DNA sequencing and genetic research. Our team of experts is dedicated to advancing scientific discovery and helping our clients unlock the potential of genomics. Through cutting-edge technology and innovative solutions, we provide a wide range of services and products to support research, diagnostics, and drug development. Visit our website to learn more about how N-GENE is shaping the future of genomics.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

14 Patents

#469 in New York, NY

#1,200 in New York

#21,588 in US

#40,857 in the World

New York, NY, United States of America

N-gene Research Laboratories, Inc.

Forward Citations = 49

36 inventors:

Balázs Sümegi (4 out of 7 patents)

Péter Literáti Nagy (3 out of 5 patents)

Zoltán Szilvássy (3 out of 3 patents)

4. Balázs Sümegi (3 out of 3 patents)

5. György Rabloczky (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

Loading…